Cassidy Bio vs Nucleai
Cassidy Bio vs Nucleai, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cassidy Bio is on 55/100 and Nucleai on 63/100.
Where each one leads
Cassidy Bio
Leads on none of the measures we hold for both companies.
Nucleai
- our overall score: 63/100 against 55/100
- agent readiness: 42/100 against 31/100
- domain rating: 29/100 against 13/100
- headcount: 66 against 15
- headcount growth: -7.0% against -67.0%
- funding raised: $58.5M against $20.0M
- LinkedIn following: 18,902 against 1,252
At a glance
| Measure | Cassidy Bio | Nucleai |
|---|---|---|
| What it is | Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions. | AI-powered spatial biology platform for precision medicine and drug development. |
| Category | Workflows, Biotech, Genomics, Drug Discovery | Healthcare, Oncology, Pharmaceutical, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2023 | 2018 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Cassidy Bio | Nucleai |
|---|---|---|
| Employees | 15 | 66 |
| Headcount growthLast 12 months | -67.0% | -7.0% |
| Total funding | $20.0M | $58.5M |
| Latest round | Not published | Series B |
| LinkedIn followers | 1,252 | 18,902 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cassidy Bio | Nucleai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 63/100 |
| Traction | 49/100 | 57/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 37/100 | 31/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cassidy Bio | Nucleai |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager, Linkedin Insight, Facebook Pixel |
| Support stack | Not detected | HubSpot |
Product and pricing
| Measure | Cassidy Bio | Nucleai |
|---|---|---|
| Key features | gRNA design, Accelerate, Expand & Optimize, De-Risk | Not published |
Cassidy Bio vs Nucleai: common questions
Which is better, Cassidy Bio or Nucleai?
On our 0-100 score Nucleai rates higher (63/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Cassidy Bio and Nucleai compare on the numbers?
Nucleai leads on our overall score (63/100 against 55/100), agent readiness (42/100 against 31/100), domain rating (29/100 against 13/100), headcount (66 against 15), headcount growth (-7.0% against -67.0%), funding raised ($58.5M against $20.0M), LinkedIn following (18,902 against 1,252).
Read the full Cassidy Bio review and pricing or the Nucleai review and pricing. You can also browse other Cassidy Bio alternatives we track.